Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech ranked by total debt, at PLN 219.4B, ahead of Gilead Sciences (PLN 100.2B) and Biogen (PLN 25.3B). Figures as of 18 Nov 2026, 13:34 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenPLN 219.4B
Median
PLN 2.4B
Combined market value
PLN 3.41T
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CarePLN 219.4BPLN 995.4BPLN 1,840.23 0.95% down 34% up United States
2Gilead SciencesGILD · Health CarePLN 100.2BPLN 848.6BPLN 684.20 1.60% up 33% up United States
3BiogenBIIB · Health CarePLN 25.3BPLN 149BPLN 1,007.82 0.34% down 49% up United States
4Halozyme TherapeuticsHALO · Health CarePLN 8.6BPLN 44BPLN 385.66 0.55% down 37% up United States
5QiagenQGEN · Health CarePLN 6.6BPLN 41.3BPLN 199.92 0.12% down 12% up Netherlands
6ModernaMRNA · Health CarePLN 2.4BPLN 336.3BPLN 831.04 3.93% down 755% up United States
7RepligenRGEN · Health CarePLN 2.2BPLN 41.7BPLN 651.73 0.37% down 5% up United States
8Bio-TechneTECH · Health CarePLN 803.7MPLN 45.8BPLN 291.87 0.22% down 26% up United States
9Adaptive BiotechnologiesADPT · Health CarePLN 527.3MPLN 18.5BPLN 114.49 2.22% up 88% up United States
10Scholar Rock HoldingSRRK · Health CarePLN 400.7MPLN 22.1BPLN 181.16 1.21% up 14% up United States
11CG OncologyCGON · Health CarePLN 12.1MPLN 28.3BPLN 317.23 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0186 PLN). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech rank first by total debt?

Amgen (PLN 219.4B), Gilead Sciences (PLN 100.2B) and Biogen (PLN 25.3B) are the top three of the 11 biotech ranked by total debt as of 18 Nov 2026, 13:34 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of PLN 3.41T as of 18 Nov 2026, 13:34 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.